Download FREE Report Sample
Download Free sampleCirculating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Circulating Tumor Cells Market contains market size and forecasts of Circulating Tumor Cells in Global, including the following market information:
Global Circulating Tumor Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Circulating Tumor Cells market was valued at 1630.5 million in 2021 and is projected to reach US$ 5681.6 million by 2028, at a CAGR of 19.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CTC Enrichment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech and Fluxion Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Circulating Tumor Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Circulating Tumor Cells Market Segment Percentages, by Type, 2021 (%)
CTC Enrichment
CTC Detection
CTC Analysis
Global Circulating Tumor Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Circulating Tumor Cells Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Global Circulating Tumor Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Circulating Tumor Cells Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Circulating Tumor Cells revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Circulating Tumor Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
